Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Recombinant production of Epstein-Barr virus BZLF1 trans-activator and characterization of its DNA-binding specificity.

Lim CS, Goh SL, Krishnan G, Ng CC.

Protein Expr Purif. 2014 Mar;95:8-12. doi: 10.1016/j.pep.2013.11.007. Epub 2013 Nov 26.

PMID:
24291446
2.

Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Kolman JL, Taylor N, Gradoville L, Countryman J, Miller G.

J Virol. 1996 Mar;70(3):1493-504.

3.

Construction and expression of a spliced variant of Epstein-Barr virus bzlf1 and preparation of its polyclonal antibody.

Qian L, Li D, Yang Z, Hu M, Yu M, Shi M, Shen B, Guo N.

Prep Biochem Biotechnol. 2010;40(1):46-56. doi: 10.1080/10826060903392780.

PMID:
20024794
5.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.

Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.

Mol Carcinog. 2002 Mar;33(3):137-45.

PMID:
11870879
6.

ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.

Taylor N, Flemington E, Kolman JL, Baumann RP, Speck SH, Miller G.

J Virol. 1991 Aug;65(8):4033-41.

8.
10.

Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Nakayama S, Murata T, Murayama K, Yasui Y, Sato Y, Kudoh A, Iwahori S, Isomura H, Kanda T, Tsurumi T.

J Biol Chem. 2009 Aug 7;284(32):21557-68. doi: 10.1074/jbc.M109.015685. Epub 2009 Jun 2.

11.

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.

J Virol. 1996 Aug;70(8):5131-42.

12.

Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.

Baumann M, Mischak H, Dammeier S, Kolch W, Gires O, Pich D, Zeidler R, Delecluse HJ, Hammerschmidt W.

J Virol. 1998 Oct;72(10):8105-14.

13.

Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.

Brousset P, Drouet E, Schlaifer D, Icart J, Payen C, Meggetto F, Marchou B, Massip P, Delsol G.

AIDS. 1994 May;8(5):583-90.

PMID:
7914731
14.

Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.

Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC.

PLoS Pathog. 2009 Mar;5(3):e1000356. doi: 10.1371/journal.ppat.1000356. Epub 2009 Mar 27.

15.

Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.

Yang EV, Webster Marketon JI, Chen M, Lo KW, Kim SJ, Glaser R.

Brain Behav Immun. 2010 Oct;24(7):1089-96. doi: 10.1016/j.bbi.2010.04.013. Epub 2010 May 11.

17.
19.

Engineering Escherichia coli BL21(DE3) derivative strains to minimize E. coli protein contamination after purification by immobilized metal affinity chromatography.

Robichon C, Luo J, Causey TB, Benner JS, Samuelson JC.

Appl Environ Microbiol. 2011 Jul;77(13):4634-46. doi: 10.1128/AEM.00119-11. Epub 2011 May 20.

20.

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.

Woellmer A, Arteaga-Salas JM, Hammerschmidt W.

PLoS Pathog. 2012 Sep;8(9):e1002902. doi: 10.1371/journal.ppat.1002902. Epub 2012 Sep 6.

Supplemental Content

Support Center